Drug
Meclizine Hcl
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Vertigo | 63 | 10.0 | 10.2 | signal |
| 2 | Hospice Care | 10 | 9.8 | 9.8 | signal |
| 3 | End Stage Renal Disease | 17 | 8.9 | 9.0 | signal |
| 4 | Economic Problem | 14 | 8.8 | 8.8 | signal |
| 5 | Full Blood Count Decreased | 17 | 8.1 | 8.2 | signal |
| 6 | Chronic Kidney Disease | 59 | 7.4 | 7.6 | signal |
| 7 | Ataxia | 9 | 7.3 | 7.3 | signal |
| 8 | Anhedonia | 19 | 6.9 | 7.0 | signal |
| 9 | Blood Count Abnormal | 11 | 6.9 | 6.9 | signal |
| 10 | Seasonal Allergy | 10 | 6.8 | 6.9 | signal |
| 11 | Temperature Intolerance | 7 | 6.6 | 6.6 | signal |
| 12 | Rib Fracture | 14 | 6.6 | 6.6 | signal |
| 13 | Multiple Sclerosis Relapse | 45 | 6.3 | 6.4 | signal |
| 14 | Increased Tendency To Bruise | 6 | 6.3 | 6.3 | signal |
| 15 | Multiple Sclerosis | 31 | 6.2 | 6.3 | signal |
| 16 | Laceration | 6 | 6.1 | 6.1 | signal |
| 17 | Product Dose Omission | 40 | 5.8 | 5.9 | signal |
| 18 | Head Injury | 19 | 5.8 | 5.8 | signal |
| 19 | Motor Dysfunction | 6 | 5.7 | 5.7 | signal |
| 20 | Localised Infection | 14 | 5.6 | 5.6 | signal |
| 21 | Urinary Incontinence | 17 | 5.5 | 5.6 | signal |
| 22 | Balance Disorder | 48 | 5.3 | 5.4 | signal |
| 23 | Nephropathy | 5 | 5.1 | 5.1 | signal |
| 24 | Knee Operation | 5 | 5.0 | 5.0 | signal |
| 25 | Initial Insomnia | 5 | 4.7 | 4.7 | signal |
| 26 | Fall | 162 | 4.7 | 5.0 | signal |
| 27 | Paralysis | 7 | 4.7 | 4.7 | signal |
| 28 | Muscle Spasticity | 6 | 4.7 | 4.7 | signal |
| 29 | Oral Herpes | 9 | 4.5 | 4.5 | signal |
| 30 | Laryngitis | 5 | 4.4 | 4.4 | signal |
| 31 | Nodule | 6 | 4.4 | 4.4 | signal |
| 32 | Ankle Fracture | 7 | 4.4 | 4.4 | signal |
| 33 | Impaired Driving Ability | 5 | 4.2 | 4.2 | signal |
| 34 | Memory Impairment | 60 | 4.2 | 4.3 | signal |
| 35 | Central Nervous System Lesion | 6 | 4.2 | 4.2 | signal |
| 36 | Blood Test Abnormal | 6 | 4.1 | 4.1 | signal |
| 37 | Vitreous Floaters | 4 | 4.0 | 4.0 | signal |
| 38 | Therapeutic Response Unexpected | 18 | 3.9 | 3.9 | signal |
| 39 | Abasia | 10 | 3.8 | 3.9 | signal |
| 40 | Hair Colour Changes | 5 | 3.8 | 3.8 | signal |
| 41 | Poisoning | 5 | 3.8 | 3.8 | signal |
| 42 | Therapy Cessation | 20 | 3.8 | 3.8 | signal |
| 43 | Hallucination | 28 | 3.6 | 3.6 | signal |
| 44 | Renal Injury | 11 | 3.5 | 3.5 | signal |
| 45 | Coronary Artery Occlusion | 5 | 3.5 | 3.5 | signal |
| 46 | Tooth Disorder | 8 | 3.4 | 3.5 | signal |
| 47 | Madarosis | 4 | 3.3 | 3.3 | signal |
| 48 | Meningioma | 5 | 3.3 | 3.3 | signal |
| 49 | Accident | 4 | 3.2 | 3.2 | signal |
| 50 | Macular Degeneration | 4 | 3.2 | 3.2 | signal |
| 51 | Plasma Cell Myeloma | 13 | 3.2 | 3.2 | signal |
| 52 | Skin Fissures | 6 | 3.1 | 3.1 | signal |
| 53 | Multiple Fractures | 5 | 2.9 | 2.9 | signal |
| 54 | Hair Texture Abnormal | 4 | 2.9 | 2.9 | no signal |
| 55 | Completed Suicide | 24 | 2.7 | 2.8 | signal |
| 56 | Breast Cancer Metastatic | 3 | 2.7 | 2.7 | no signal |
| 57 | Blood Glucose Abnormal | 5 | 2.6 | 2.6 | no signal |
| 58 | Tooth Loss | 5 | 2.3 | 2.3 | no signal |
| 59 | Drug Effect Decreased | 12 | 2.1 | 2.1 | signal |
| 60 | Emotional Distress | 26 | 2.1 | 2.1 | signal |
| 61 | Drug Dispensing Error | 3 | 1.9 | 1.9 | no signal |
| 62 | Bone Density Decreased | 6 | 1.8 | 1.8 | no signal |
| 63 | Drug Dose Omission | 30 | 1.7 | 1.7 | no signal |
| 64 | Injection Site Urticaria | 4 | 1.6 | 1.6 | no signal |
| 65 | Injection Site Mass | 6 | 1.6 | 1.6 | no signal |
| 66 | Drug Prescribing Error | 3 | 1.5 | 1.5 | no signal |
| 67 | Drug Exposure During Pregnancy | 5 | 1.4 | 1.4 | no signal |